Lactobacillus casei
Lactobacillus casei (species-level entry, undesignated strain) is a broadly studied lactic acid bacterium encountered across fermented dairy and non-dairy foods. The indexed research for this species-level entry spans diverse topics, including immune stimulation in animal models, fermentation biochemistry, and food technology applications, without converging on a single well-characterized probiotic strain. Species-level data cannot be reliably attributed to any particular commercial or clinical preparation of L. casei without strain designation, and the indexed studies here do not constitute strain-specific clinical evidence.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 3,881 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 1,368 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
+17 more symptoms
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
13899 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 41910295 →A randomized controlled trial of probiotics to reduce the severity of oral mucositis in patients with oropharyngeal carcinoma undergoing concurrent chemoradiotherapy· Journal of Cancer Research and Therapeutics · 2026
-
[2]
Source →Lactobacillus casei Shirota intervention modulates the esophageal microbiome composition in Barrett’s esophagus· medRxiv · 2025
-
[3]
Source →The Effects of Probiotic Supplementation on Treatment Outcomes of Patients with Active Tuberculosis: A Systematic Review of Randomized Controlled Trials· Journal Of The Indonesian Medical Association · 2025
-
[4]
PMID 39952876 →Nonintravesical Interventions for Preventing Intravesical Recurrence in Patients With Nonmuscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis· Clinical Genitourinary Cancer · 2025
-
[5]
PMID 40877060 →Enhanced sleep quality and reduced indoxyl sulfate levels following probiotic supplementation were linked to gut microbiota modulation in hemodialysis patients· Journal of the Formosan Medical Association · 2025
-
[6]
PMID 41221154 →Lactobacillus casei ’s Antitumor Potential in Colorectal Cancer: Exploring Mechanisms—A Systematic Review· BioMed Research International · 2025
-
[7]
PMID 39858898 →Probiotics in the Management of Chronic Bacterial Prostatitis Patients: A Randomized, Double-Blind Trial to Evaluate a Possible Link Between Gut Microbiota Restoring and Symptom Relief· Microorganisms · 2025
-
[8]
PMID 39064686 →The Effect of Probiotics on the Management of Pain and Inflammation in Osteoarthritis: A Systematic Review and Meta-Analysis of Clinical Studies· Nutrients · 2024
-
[9]
PMID 38788020 →Probiotics combined with atorvastatin administration in the treatment of hyperlipidemia: A randomized, double-blind, placebo-controlled clinical trial· Medicine · 2024
-
[10]
PMID 38519563 →Lactobacillus casei Shirota probiotic drinks reduce antibiotic associated diarrhoea in patients with spinal cord injuries who regularly consume proton pump inhibitors: a subgroup analysis of the ECLISP multicentre RCT· Spinal Cord · 2024